Position in AMGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$5,298,901
+$255,132 QoQ
Shares Held
14,633
+2.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#806
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PFG Advisors holds $28,669,367 across 8 Drug Manufacturers - General names. AMGN ranks #4 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
28,720 | $7,294,018 | |
| 2 | ABBV |
AbbVie Inc.
|
22,305 | $5,612,830 | |
| 3 | LLY |
ELI LILLY & Co
|
4,488 | $5,383,042 | |
| 4 | AMGN |
Amgen Inc
This page
|
14,633 | $5,298,901 | |
| 5 | MRK |
Merck & Co., Inc.
|
31,306 | $4,022,821 | |
| 6 | PFE |
Pfizer Inc
|
15,983 | $384,870 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,755 | $348,066 | |
| 8 | AZN |
Astrazeneca PLC
|
1,713 | $324,819 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,298,901 | 14,633 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $5,043,769 | 14,335 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $4,381,698 | 13,387 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $6,508,378 | 23,063 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,996,034 | 21,475 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,469,883 | 17,557 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,333,064 | 12,788 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $4,156,509 | 12,900 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $4,360,552 | 13,956 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,965,695 | 13,948 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $4,004,630 | 13,904 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $3,755,921 | 13,975 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $3,043,006 | 13,706 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $3,208,264 | 13,271 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $3,524,628 | 13,420 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $3,013,598 | 13,370 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $3,204,990 | 13,173 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $3,190,331 | 13,193 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $2,817,749 | 12,525 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $2,624,951 | 12,344 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $3,126,337 | 12,826 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,894,157 | 11,632 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $2,595,566 | 11,289 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $2,774,664 | 10,917 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,619,697 | 11,107 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $2,271,792 | 11,206 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||